“Rogue antibodies” that seem to trigger severe blood clotting and illness in COVID-19 patients have been identified by scientists. Their analysis of blood samples from 244 patients hospitalized for COVID-19 revealed circulating antiphospholipid antibodies, which are autoantibodies that target a person’s own organs and systems. These autoantibodies are more common in people with autoimmune disorders,… read on > read on >



















